Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: An EORTC gynecological cancer cooperative group study
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 22 (3) , 313-316
- https://doi.org/10.1016/0090-8258(85)90045-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Progestogen therapy for ovarian carcinomaBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- A Study of Estrogen and Progesterone Cytosol Receptor Concentration in Benign and Malignant Ovarian Tumors and A Review of Malignant Ovarian Tumors Treated with Medroxy‐Progesterone AcetateActa Obstetricia et Gynecologica Scandinavica, 1981
- Steroid receptor protein in ovarian malignanciesGynecologic Oncology, 1980
- "INCESSANT OVULATION" AND OVARIAN CANCERThe Lancet, 1979
- Ovarian cancer.Incidence and case-control studyCancer, 1979
- DOES PREGNANCY PROTECT AGAINST OVARIAN CANCER?The Lancet, 1978
- Management of Ovarian CarcinomaNew England Journal of Medicine, 1976
- PROGESTOGEN THERAPY FOR OVARIAN CARCINOMABJOG: An International Journal of Obstetrics and Gynaecology, 1972
- EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE 17-N-CAPROATE ON VARIOUS PELVIC MALIGNANCIES1964
- Progesterone in the Treatment of Advanced Malignant Tumours of Breast, Ovary and UterusBritish Journal of Cancer, 1962